Healthcare Investors Reprice Risk While Demand Remains Strong

Healthcare real estate investors are reassessing risk in 2026—not demand.

Capital is returning to the sector, particularly for core and specialty assets, but investors and lenders are applying more disciplined underwriting standards as they deploy capital.

Capital Returns With Greater Selectivity

According to Partner Valuation Advisors, healthcare real estate is once again attracting investor interest, though not indiscriminately. The sector’s underlying fundamentals—including high occupancy levels and durable cash flows—remain intact. What has changed is how investors evaluate and price risk.

Rather than stretching valuations to secure deals, market participants are recalibrating return expectations and risk thresholds while maintaining confidence in long-term, need-based healthcare demand.

This shift is evident across both debt and equity markets. Financing conditions have improved from the volatility experienced over the past two years, with lender spreads narrowing and credit becoming more accessible for qualified borrowers.

However, capital remains highly selective. Investors and lenders are prioritizing assets with strong utilization, strategic alignment with health systems or physician groups, and locations that offer meaningful barriers to entry. Capital is available, but the definition of what qualifies as a core healthcare asset has become more stringent.

Liquidity Concentrates Around Core And Specialty Assets

Transaction activity reflects a repricing of risk rather than a weakening of demand. Institutional-quality medical office buildings and hospital-adjacent facilities continue to command strong pricing, underscoring investor confidence in mission-critical healthcare real estate.

Recent acquisitions of major healthcare campuses and hospital-related properties demonstrate continued conviction in assets supported by long-term patient demand and strategic healthcare infrastructure. At the same time, capital is not being deployed evenly across the sector. Liquidity has become concentrated among core and core-plus assets, while secondary properties face extended marketing periods and heightened scrutiny from buyers and lenders.

This growing bifurcation is less about patient demand and more about confidence in an asset’s credit profile, functionality, operational relevance, and long-term strategic value. Investors continue to believe patients will use healthcare facilities; the question is which facilities are best positioned to capture and sustain that demand.

Specialty sectors such as behavioral health and inpatient rehabilitation have emerged as increasingly important investment themes. Partner Valuation Advisors notes growing capital flows into these segments, supported by favorable demographics, rising clinical demand, and limited new supply. Even in these areas, investors are applying greater scrutiny to operator quality, reimbursement exposure, and lease structures. Yet the long-term demand outlook remains one of the sector’s strongest investment drivers.

Medical Office Remains The Risk Benchmark

Medical office continues to serve as the benchmark for acceptable risk within healthcare real estate. National occupancy has remained in the low-90% range for years, supported by steady demand and consistent rent growth. That stability has reinforced medical office’s position as the sector’s core investment product. Well-located, institutionally sized buildings with strong tenant rosters continue to attract both capital and financing.

While investors are generally unwilling to return to the aggressive pricing levels seen before 2022, they remain comfortable accepting lower yields on assets that combine stable utilization with clear alignment to outpatient care delivery and health system strategies.

For many investors, medical office represents the “core within the core”—the asset class where capital can be deployed with the greatest confidence as portfolios are repositioned for the next phase of the market cycle.

Development Reopens Selectively

Development activity is beginning to reemerge, but only where demand fundamentals are exceptionally strong. Developers and capital partners are advancing projects tied to outpatient expansion, specialty care delivery, and broader health system network strategies. Facilities that alleviate capacity constraints or support long-term shifts in care delivery continue to attract interest despite elevated development costs.

Higher construction and financing expenses have not halted development altogether, but they have significantly increased the hurdles for project approval. Projects lacking clear evidence of sustained utilization, durable tenancy, and strategic relevance within a provider network are finding it difficult to secure financing. Conversely, developments that satisfy these requirements are attracting capital, reflecting continued confidence in healthcare demand when supported by strong underwriting.

The 2026 Healthcare Real Estate Playbook

Partner Valuation Advisors’ assessment of the 2026 market points to a clear investment strategy: focus on assets supported by durable, need-based demand and strong operational fundamentals. Whether investing in core medical office, hospital-adjacent properties, or specialty healthcare facilities, investors are dedicating greater attention to operator quality, lease structures, reimbursement dynamics, and the asset’s role within the local healthcare ecosystem.

Healthcare real estate is not falling out of favor—it is being re-ranked. Capital that remained sidelined during recent uncertainty is returning with a more defined view of acceptable risk and a sharper distinction between premium and secondary assets.

Ultimately, the debate is no longer whether patients will continue to seek care. The focus has shifted to identifying the buildings, operators, and capital structures best positioned to translate that demand into durable performance throughout the next stage of the cycle.

Source: GlobeSt